Printer Friendly

The bottom line.

The Bottom Line
Data from recent industry financial reports. Dollar amounts in millions.

Company                    Period   Ended      Sales    Chg.

ACLARA BioSciences           2Q     30-Jun   $   0.8   -10.6%
Axon Instruments             1H     30-Jun   $  18.5    43.4%
Bioanalytical Systems        3Q     30-Jun   $   6.4    17.4%
CRS Robotics                 2Q     30-Jun   $   7.2    93.0%
Harvard Bioscience           2Q     30-Jun   $   9.7    31.4%
IGEN International           1Q     30-Jun   $   8.3     9.0%
InVision Technologies        2Q     1-Jul    $  17.4     2.5%
Ionics                       2Q     30-Jun   $ 113.7    10.6%
MTS Corp.                    3Q     30-Jun   $  98.6     3.8%
Nanometrics                  2Q     30-Jun   $  14.8   -11.4%
Orchid BioSciences, Inc.     2Q     30-Jun   $   6.7    46.2%
Osmonics                     2Q     30-Jun   $  51.7     3.2%
Pyrosequencing AB            2Q     30-Jun   $  13.6   148.4%
Rheometric Scientific        1Q     31-Mar   $   7.6    15.5%
Rheometric Scientific        2Q     30-Jun   $   7.4   -5.3%
Tripos, Inc.                 2Q     30-Jun   $  10.6    93.6%
Zygo                         4Q     30-Jun   $  37.9    58.7%
Zygo                        FYE     30-Jun   $ 133.3    52.7%

Company                    Op. Prof.   Chg.    Net Prof.    Chg.

ACLARA BioSciences          $  (5.2)       NM    $   (3.2)      NM
Axon Instruments                N/A       N/A    $    1.0    11.1%
Bioanalytical Systems       $  (0.9)       NM    $   (0.5)      NM
CRS Robotics                $   0.3    111.0%    $    0.0   -79.3%
Harvard Bioscience          $   1.2      1.3%    $    1.0    96.2%
IGEN International          $  (6.4)       NM    $  (11.9)      NM
InVision Technologies       $  (0.3)       NM    $   (0.1)      NM
Ionics                      $   5.8    -15.0%    $    4.2    -1.1%
MTS Corp.                   $   9.0     38.1%    $    4.4    20.3%
Nanometrics                 $   1.8    -46.8%    $    1.5   -47.9%
Orchid BioSciences, Inc.    $ (15.1)       NM    $  (14.3)      NM
Osmonics                    $   2.6     -3.2%    $    1.2   -37.2%
Pyrosequencing AB           $  (4.3)       NM    $   (3.6)      NM
Rheometric Scientific       $   0.2     93.3%    $   (0.4)      NM
Rheometric Scientific       $  (0.0)       NM    $   (0.5)      NM
Tripos, Inc.                $   1.1        NM    $    2.3       NM
Zygo                        $   4.5        NM    $    4.7       NM
Zygo                        $  13.6        NM    $   10.7       NM

NA = not available

NM = not meaningful
COPYRIGHT 2001 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2001 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:financial reports from top bioscience, instrument companies
Comment:The bottom line.(financial reports from top bioscience, instrument companies)
Publication:Instrument Business Outlook
Article Type:Brief Article
Geographic Code:1USA
Date:Sep 15, 2001
Words:326
Previous Article:Market profile: gloss meters.
Next Article:Pittcon 2002 exceeds lowered expectations.
Topics:


Related Articles
NEW PUBLISHING PACTS BOLSTER OVID'S SCIENCE OFFERINGS.
Incontinence Brief With Moisture Indicating Strip.
2001: The year of the microarray?
The bottom line.
The Bottom Line: data from recent industry financial reports. Dollar amount in millions.
The bottom line: data from recent industry financial reports. Dollar amounts in millions.
The bottom line.
The bottom line.
The bottom line.
Affordable on-line spectrophotometer.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters